Cryoablation Devices

Global Cryoablation Devices Market to Reach US$1.0 Billion by 2030

The global market for Cryoablation Devices estimated at US$462.9 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Tissue Contact Probe Ablators, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$564.9 Million by the end of the analysis period. Growth in the Tissue Spray Probe Ablators segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$126.1 Million While China is Forecast to Grow at 18.9% CAGR

The Cryoablation Devices market in the U.S. is estimated at US$126.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$219.2 Million by the year 2030 trailing a CAGR of 18.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.

Global Cryoablation Devices Market – Key Trends & Growth Drivers Summarized

Why Is Cryoablation Gaining Popularity in Modern Healthcare?

Cryoablation, a minimally invasive procedure that uses extreme cold to destroy abnormal tissues, has gained significant traction in modern healthcare due to its effectiveness in treating various conditions, including cancer, cardiac arrhythmias, and chronic pain. Unlike traditional surgical methods, cryoablation offers advantages such as reduced recovery time, minimal scarring, and lower risks of infection. The growing prevalence of diseases such as atrial fibrillation (AF), kidney tumors, and lung cancer has fueled the demand for cryoablation devices as a safer and more precise alternative to conventional treatments. Additionally, advancements in imaging technology, such as real-time ultrasound and MRI guidance, have improved the accuracy of cryoablation procedures, making them more reliable and accessible. As healthcare systems worldwide move toward less invasive treatment options, the adoption of cryoablation is expected to rise, particularly in oncology and cardiology. However, despite its advantages, factors such as high procedural costs and the need for specialized training for healthcare professionals remain challenges to widespread adoption.

What Are the Latest Technological Innovations in Cryoablation Devices?

The cryoablation devices market has seen rapid technological advancements, enhancing the precision, safety, and effectiveness of the procedure. Modern cryoablation systems now integrate advanced temperature control mechanisms to prevent damage to surrounding healthy tissues while ensuring optimal freezing of targeted cells. The introduction of catheter-based cryoablation systems has revolutionized the treatment of atrial fibrillation, allowing for minimally invasive ablation of abnormal cardiac tissue through vascular access. Additionally, innovations in probe design, such as multi-probe cryoablation systems, have enabled simultaneous treatment of multiple tumors, increasing efficiency in oncology applications. The integration of artificial intelligence (AI) and robotics in cryoablation procedures is another game-changing development, providing real-time feedback and automated adjustments to enhance precision. Furthermore, advancements in cryogenic gas delivery systems, including the use of argon and liquid nitrogen, have improved freezing efficiency while reducing procedural time. As these innovations continue to evolve, cryoablation devices are becoming more sophisticated, allowing for expanded applications beyond traditional use cases in cancer and cardiology.

How Are Regulatory and Market Trends Influencing the Cryoablation Industry?

Regulatory approvals and market trends play a crucial role in shaping the adoption and growth of cryoablation devices. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have streamlined the approval process for cryoablation devices in response to increasing clinical evidence supporting their efficacy and safety. Additionally, reimbursement policies for minimally invasive procedures have improved in various countries, making cryoablation more accessible to patients. The rising geriatric population, particularly in North America, Europe, and Japan, has also contributed to market growth, as elderly patients often require less invasive treatment options for conditions such as cardiac arrhythmias and prostate cancer. Furthermore, strategic collaborations between medical device companies and hospitals are driving market expansion, with leading manufacturers investing in research and development to improve product offerings. Another key market trend is the shift toward outpatient cryoablation procedures, as healthcare facilities aim to reduce hospitalization costs while offering effective treatment options. However, market penetration in emerging economies remains a challenge due to limited healthcare infrastructure and awareness about cryoablation’s benefits.

What Is Driving the Growth of the Cryoablation Devices Market?

The growth in the cryoablation devices market is driven by several factors, including the increasing prevalence of cancer and cardiovascular diseases, advancements in cryoablation technology, and the demand for minimally invasive treatment options. The rising adoption of image-guided cryoablation procedures, particularly in oncology, has enabled more precise and effective tumor targeting, leading to higher treatment success rates. Additionally, the development of disposable cryoablation catheters has reduced the risk of cross-contamination and enhanced procedural safety, driving higher adoption among healthcare providers. The expansion of cryoablation applications beyond traditional areas, such as in dermatology for wart and lesion removal, has further contributed to market growth. Furthermore, the increasing availability of cryoablation systems in ambulatory surgical centers (ASCs) and outpatient clinics has made the procedure more accessible, reducing hospital dependency. The integration of AI-powered diagnostic tools and robotic-assisted cryoablation procedures is expected to further accelerate market growth by improving procedural accuracy and reducing operator dependency. As research and development efforts continue to push the boundaries of cryoablation technology, the market is poised for sustained growth, with increasing adoption across multiple medical specialties and global regions.

SCOPE OF STUDY:

The report analyzes the Cryoablation Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Tissue Contact Probe Ablators, Tissue Spray Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems); Application (Cardiac Arrhythmia Application, Lung Cancer Application, Liver Cancer Application, Breast Cancer Application, Other Applications); End-Use (Hospital End-Use, Outpatient Facilities End-Use, Research and Manufacturing End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• AngioDynamics
• AngioDynamics, Inc.
• AtriCure, Inc.
• Boston Scientific Corporation
• BVM Medical Ltd.
• CooperSurgical, Inc.
• CPSI Biotech
• CryoConcepts LP
• Erbe Elektromedizin GmbH
• Galil Medical Ltd.
• HealthTronics, Inc.
• Hygea Medical Technology
• IceCure Medical
• Johnson & Johnson
• Medtronic plc
• METRUM CRYOFLEX
• MicroPort Scientific Corp.
• Olympus Corporation
• Stryker Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.